Glybera, a made-in-Canada medical breakthrough that became known as the world's most expensive drug, was abandoned after only one commercial sale in Europe. After seeing a CBC report on Glybera's fate, Canada's National Research Council decided to develop an affordable version for Canadians.
How an alleged Russian plot suddenly upended Canada's air cargo rulesFormer employees say 'toxic work environment' of N.S. mental health non-profit led to sudden closureCanadian government speaking with allies about Palestinian statehood recognition, official tells MPs16-year-old Ontario girl recovering after vicious attack, ex-boyfriend charged with attempted murder'Like out of a movie': Tornado touches down in Sechelt, B.C.
0 comments:
Post a Comment